AMED has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMED has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Amedisys's Degree of Operating Leverage for the quarter that ended in Mar. 2025 was 33.70. The higher Degree of Operating Leverage, the higher operating risk the company will take.
The industry rank for Amedisys's Degree of Operating Leverage or its related term are showing as below:
The historical data trend for Amedisys's Degree of Operating Leverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Degree of Operating Leverage | Get a 7-Day Free Trial |
![]() |
![]() |
3.37 | 4.45 | -90.22 | -103.12 | 12.99 |
Amedisys Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Degree of Operating Leverage | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-83.73 | 50.50 | 25.48 | 12.99 | 33.70 |
For the Medical Care Facilities subindustry, Amedisys's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Degree of Operating Leverage distribution charts can be found below:
* The bar in red indicates where Amedisys's Degree of Operating Leverage falls into.
Amedisys's Degree of Operating Leverage for the quarter that ended in Mar. 2025 is calculated as:
Degree of Operating Leverage | = | % Change in EBIT** | / | % Change in Revenue |
= | ( 179.261 (Mar. 2025) / 64.017 (Mar. 2024) - 1 ) | / | ( 2371.691 (Mar. 2025) / 2251.407 (Mar. 2024) - 1 ) | |
= | 1.8002 | / | 0.0534 | |
= | 33.70*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Amedisys (NAS:AMED) Degree of Operating Leverage Explanation
Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.
A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.
Be Aware
The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.
Thank you for viewing the detailed overview of Amedisys's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Allyson Guidroz | officer: Chief Accounting Officer | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
Richard M Ashworth | director, officer: President and CEO | 200 WILMOT ROAD, DEERFIELD IL 60015 |
Michael Paul North | officer: Chief Information Officer | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
Adam Y Holton | officer: Chief People Officer | C/O CHS INC., 5500 CENEX DRIVE, INVER GROVE HEIGHTS MN 55077 |
Denise M. Bohnert | officer: Chief Compliance Officer | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
Nick Muscato | officer: Chief Strategy Officer | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
Richard A Lechleiter | director | PO BOX 32890, LOUISVILLE KY 40232-2890 |
Bruce D Perkins | director | 500 WEST MAIN STREET, LOUISVILLE KY 40202 |
Christopher Gerard | officer: Chief Operating Officer | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
Vickie L Capps | director | 2985 SCOTT STREET, VISTA CA 92083 |
Teresa L. Kline | director | C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
Jeffrey A Rideout | director | 2142 DEER OAK WAY, DANVILLE CA 94506 |
Julie D Klapstein | director | 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259 |
Molly Joel Coye | director | AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
David L Kemmerly | officer: See Remarks | 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816 |
From GuruFocus
By GuruFocus News • 04-23-2025
By GuruFocus News • 02-26-2025
By GuruFocus Research • 02-06-2024
By GuruFocus News • 12-03-2024
By GuruFocus News • 04-23-2025
By GuruFocus Research • 07-24-2024
By Marketwired • 07-24-2024
By GuruFocus Research • 02-06-2024
By Marketwired • 11-06-2024
By Marketwired • 02-03-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.